These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 1449515)
1. Accessibility of aminoglycosides, isolated and in interaction with phosphatidylinositol, to water. A conformational analysis using the concept of molecular hydrophobicity potential. Mingeot-Leclercq MP; Tulkens PM; Brasseur R Biochem Pharmacol; 1992 Nov; 44(10):1967-75. PubMed ID: 1449515 [TBL] [Abstract][Full Text] [Related]
2. Effect of acidic phospholipids on the activity of lysosomal phospholipases and on their inhibition induced by aminoglycoside antibiotics--II. Conformational analysis. Mingeot-Leclercq MP; Piret J; Tulkens PM; Brasseur R Biochem Pharmacol; 1990 Aug; 40(3):499-506. PubMed ID: 2383283 [TBL] [Abstract][Full Text] [Related]
3. Interaction of streptomycin and streptomycylamine derivatives with negatively charged lipid layers. Correlation between binding, conformation of complexes and inhibition of lysosomal phospholipase activities. Brasseur R; Carlier MB; Laurent G; Claes PJ; Vanderhaeghe HJ; Tulkens PM; Ruysschaert JM Biochem Pharmacol; 1985 Apr; 34(7):1035-47. PubMed ID: 3985990 [TBL] [Abstract][Full Text] [Related]
4. Interactions of aminoglycoside antibiotics with negatively charged lipid layers. Biochemical and conformational studies. Brasseur R; Laurent G; Ruysschaert JM; Tulkens P Biochem Pharmacol; 1984 Feb; 33(4):629-37. PubMed ID: 6704179 [TBL] [Abstract][Full Text] [Related]
5. Effect of acidic phospholipids on the activity of lysosomal phospholipases and on their inhibition by aminoglycoside antibiotics--I. Biochemical analysis. Mingeot-Leclercq MP; Piret J; Brasseur R; Tulkens PM Biochem Pharmacol; 1990 Aug; 40(3):489-97. PubMed ID: 2383282 [TBL] [Abstract][Full Text] [Related]
6. Molecular parameters involved in aminoglycoside nephrotoxicity. Mingeot-Leclercq MP; Brasseur R; Schanck A J Toxicol Environ Health; 1995 Mar; 44(3):263-300. PubMed ID: 7897692 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of kidney lysosomal phospholipase A1 by aminoglycosides is a novel variant of substrate depletion inhibition. Hostetler KY; Jellison EJ J Pharmacol Exp Ther; 1990 Jul; 254(1):188-91. PubMed ID: 2366181 [TBL] [Abstract][Full Text] [Related]
9. In vitro inhibition of lysosomal phospholipases by aminoglycoside antibiotics: a comparative study. Carlier MB; Laurent G; Tulkens P Arch Toxicol Suppl; 1984; 7():282-5. PubMed ID: 6595993 [TBL] [Abstract][Full Text] [Related]
10. Interactions of aminoglycoside antibiotics with phospholipids. A deuterium nuclear magnetic resonance study. Schanck A; Mingeot-Leclercq MP; Tulkens PM; Carrier D; Smith IC; Jarrell HC Chem Phys Lipids; 1992 Sep; 62(2):153-63. PubMed ID: 1423808 [TBL] [Abstract][Full Text] [Related]
11. Aminoglycoside antibiotics inhibit lysosomal phospholipase A and C from rat liver in vitro. Hostetler KY; Hall LB Biochim Biophys Acta; 1982 Mar; 710(3):506-9. PubMed ID: 7074128 [TBL] [Abstract][Full Text] [Related]
12. Effects of aminoglycosides on proximal tubule brush border membrane phosphatidylinositol-specific phospholipase C. Schwertz DW; Kreisberg JI; Venkatachalam MA J Pharmacol Exp Ther; 1984 Oct; 231(1):48-55. PubMed ID: 6092605 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of kidney lysosomal phospholipases A and C by aminoglycoside antibiotics: possible mechanism of aminoglycoside toxicity. Hostetler KY; Hall LB Proc Natl Acad Sci U S A; 1982 Mar; 79(5):1663-7. PubMed ID: 6951205 [TBL] [Abstract][Full Text] [Related]
14. Biochemical mechanism of aminoglycoside-induced inhibition of phosphatidylcholine hydrolysis by lysosomal phospholipases. Mingeot-Leclercq MP; Laurent G; Tulkens PM Biochem Pharmacol; 1988 Feb; 37(4):591-9. PubMed ID: 3342096 [TBL] [Abstract][Full Text] [Related]
15. New derivatives of kanamycin B obtained by modifications and substitutions in position 6''. 2. In vitro and computer-aided toxicological evaluation with respect to interactions with phosphatidylinositol. Mingeot-Leclercq MP; Van Schepdael A; Brasseur R; Busson R; Vanderhaeghe HJ; Claes PJ; Tulkens PM J Med Chem; 1991 Apr; 34(4):1476-82. PubMed ID: 2016725 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antimicrobial and toxicological studies of amino acid and peptide derivatives of kanamycin A and netilmicin. Kotretsou S; Mingeot-Leclercq MP; Constantinou-Kokotou V; Brasseur R; Georgiadis MP; Tulkens PM J Med Chem; 1995 Nov; 38(23):4710-9. PubMed ID: 7473599 [TBL] [Abstract][Full Text] [Related]
17. Ultrastructural, physico-chemical and conformational study of the interactions of gentamicin and bis(beta-diethylaminoethylether) hexestrol with negatively-charged phospholipid layers. Mingeot-Leclercq MP; Schanck A; Ronveaux-Dupal MF; Deleers M; Brasseur R; Ruysschaert JM; Laurent G; Tulkens PM Biochem Pharmacol; 1989 Mar; 38(5):729-41. PubMed ID: 2539158 [TBL] [Abstract][Full Text] [Related]
18. The effects of polyamines and aminoglycosides on phosphatidylinositol-specific phospholipase C from human amnion. Sagawa N; Bleasdale JE; Di Renzo GC Biochim Biophys Acta; 1983 Jun; 752(1):153-61. PubMed ID: 6849963 [TBL] [Abstract][Full Text] [Related]
19. Docking of cationic antibiotics to negatively charged pockets in RNA folds. Hermann T; Westhof E J Med Chem; 1999 Apr; 42(7):1250-61. PubMed ID: 10197968 [TBL] [Abstract][Full Text] [Related]
20. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin. Laurent G; Carlier MB; Rollman B; Van Hoof F; Tulkens P Biochem Pharmacol; 1982 Dec; 31(23):3861-70. PubMed ID: 7159463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]